Macquarie initiates an ‘Underperform’ rating on Swiggy, giving it a target price of Rs 325. They believe that while Swiggy has growth potential, profitability remains a challenge, particularly in the quick commerce segment. Swiggy’s IPO, meanwhile, saw a decent subscription rate and is set to debut on the stock exchange.
Global Health Q2 Results: Medanta operator posts 5% rise in net profit YoY at Rs 131 crore
Global Health, which operates hospitals under the Medanta brand, on Thursday said its profit after tax increased 5 per cent to Rs 131 crore in